Influenza Virus Vaccine, Live Dosage
Medically reviewed by Drugs.com. Last updated on Sep 30, 2024.
Applies to the following strengths: trivalent; quadrivalent
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Influenza Prophylaxis
PATIENTS UP TO 49 YEARS: 0.2 mL intranasally once
Comments:
- The dose should be administered as a 0.1 mL dose per nostril.
- Active inhalation (sniffing) is not needed during administration.
Use: Active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
Usual Pediatric Dose for Influenza Prophylaxis
PATIENTS 2 TO 8 YEARS: 0.2 mL intranasally once OR in two-0.2 mL separate doses
PATIENTS 9 YEARS AND OLDER: 0.2 mL intranasally once
Comments:
- The dose should be administered as a 0.1 mL dose per nostril.
- If administering 2 doses, doses should be given at least 1 month apart.
- The Advisory Committee on Immunization Practices (ACIP) should be consulted regarding annual recommendations to determine the number of doses.
- Active inhalation (sniffing) is not needed during administration.
Use: Active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Severe allergic reaction (e.g., anaphylaxis) to the active component or any of the ingredients, including egg protein
- Severe allergic reaction after a previous dose of any influenza vaccine
- Concomitant aspirin or aspirin-containing therapy in children and adolescents
Safety and efficacy have not been established in patients younger than 2 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Do not inject.
- The manufacturer product information should be consulted.
Storage requirements:
- Refrigerate; do not freeze.
- Keep in carton to protect from light.
- Each dose must contain 0.2 mL of vaccine.
Reconstitution/preparation techniques:
- The manufacturer product information should be consulted.
Patient advice:
- To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS): https://vaers.hhs.gov
- Inform patients/caregivers that this is an attenuated live virus vaccine and has the potential for transmission to immunocompromised contacts.
More about influenza virus vaccine, live
- Check interactions
- Compare alternatives
- Reviews (15)
- Side effects
- During pregnancy
- Drug class: viral vaccines
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.